The Current Ratio as of December 2025 (TTM) for Meribank Biotech Co., Ltd (4724.TWO) is 1.58

According to Meribank Biotech Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 1.58. This represents a change of -39.54% compared to the average of 2.61 of the last 4 quarters.

Meribank Biotech Co., Ltd (4724.TWO) Historical Current Ratio (quarterly & annually)

How has 4724.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Meribank Biotech Co., Ltd over the last ten years is 3.06. The current 1.58 Current Ratio has changed 5.06% with respect to the historical average. Over the past ten years (40 quarters), 4724.TWO's Current Ratio was at its highest in in the December 2023 quarter at 4.49. The Current Ratio was at its lowest in in the June 2022 quarter at 0.

Meribank Biotech Co., Ltd (4724.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Meribank Biotech Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Meribank Biotech Co., Ltd (4724.TWO) Average Current Ratio

How has 4724.TWO Current Ratio performed in the past?

The current Current Ratio of Meribank Biotech Co., Ltd (4724.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Meribank Biotech Co., Ltd (4724.TWO) Current Ratio vs. Peers

How is 4724.TWO’s Current Ratio compared to its peers?

Meribank Biotech Co., Ltd’s Current Ratio is less than NaviFUS Corp. (15.39), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (3.34), less than Advagene Biopharma Co., Ltd. (30.83), greater than Enimmune corporation (1.41), greater than Genomics BioSci & Tech. Co.,Ltd. (1.35), less than GenMont Biotech Incorporation (4.82), less than Great Novel Therapeutics Biotech & Medicals (30.32), less than GeneReach Biotechnology Corp. (2.39), greater than Sunny Pharmtech Inc. (1.30), less than Abnova (Taiwan) Corporation (15.77),

Build a custom stock screener for Meribank Biotech Co., Ltd (4724.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Meribank Biotech Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Meribank Biotech Co., Ltd (4724.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Meribank Biotech Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.